Concepedia

Dev Leibowitz

DL

Statistics

Publications

1

Citations

17

H-Index

1

Active since

2022

Affiliations

Columbia University Irving Medical Center(Current)

Dev Leibowitz is an author at Columbia University Irving Medical Center specializing in targeted cancer therapy, combination immunotherapy, and tumor immunology.

Publications per year

2022–2022

1

Publications

1

Evaluating the Combined Anticancer Response of Checkpoint Inhibitor Immunotherapy and FAP-Targeted Molecular Radiotherapy in Murine Models of Melanoma and Lung Cancer

Kathleen M. Capaccione, Mikhail Doubrovin, Brian Braumuller et al. · Cancers · 2022 · 17 citations · Full text

, , +17

1–1 of 1